Overall Status

Completed (84)

Terminated (28)

Recruiting (24)

Active, not recruiting (15)

Withdrawn (10)

Unknown status (9)

Not yet recruiting (8)

No longer available (1)

Phase

phase 2 (100)

phase 1/phase 2 (25)

phase 1 (20)

n/a (13)

phase 3 (8)

phase 2/phase 3 (5)

phase 4 (4)

early phase 1 (1)

Study Documents

Intervention Type

drug (168)

procedure (87)

biological (35)

radiation (29)

other (27)

device (9)

genetic (2)

behavioral (1)

diagnostic test (1)

Funder Type

Other (169)

NIH (7)

Industry (3)

Study Type

Interventional (176)

Expanded Access (1)

Observational (1)

Observational [Patient Registry] (1)

busulfex

Showing 176 - 179 of 179

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Myeloid Leukemia Trial in New York (Reduced Intensity Conditioning, Busulfan and Fludarabine)

Terminated

Chronic Myeloid Leukemia

Reduced Intensity Conditioning, Busulfan and Fludarabine

New York, New York

Morgan Stanley Children's Hospital of NYP

Apr 12, 2011

Leukemia, Myelodysplastic Syndrome Trial in Seoul (BuCy vs BuFlu)

Completed

Leukemia
Myelodysplastic Syndrome

BuCy vs BuFlu

Seoul, Korea, Republic of

Asan Medical Center

Feb 10, 2011

Solid Tumors, Hematologic Tumors Trial in Clermont-Ferrand (Fludarabine, Busulfan, Thymoglobulin)

Unknown status

Solid Tumors
Hematologic Neoplasms

Fludarabine, Busulfan, Thymoglobulin

Clermont-Ferrand, France

Paillard Catherine

Jan 18, 2011

Stem Cell Transplantation, Graft Vs Host Disease Trial in Jerusalem (Thymoglobuline)

Completed

Stem Cell Transplantation
Graft Vs Host Disease

Thymoglobuline

Jerusalem, Israel

Hadassah Medical Organization

Feb 22, 2011